ASAnina Seidemo

Anina Seidemo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anina Seidemo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Linda Knutsson

    Department of Medical Radiation Physics Lund University Lund Sweden

    6 shared publications
  • Nirbhay N. Yadav

    F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA

    3 shared publications
  • Peter C. M. van Zijl

    F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, USA

    3 shared publications
  • Peter C. M. van Zijl

    F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD (S.S., H.-G.S., P.v.Z., L.K.).

    3 shared publications
  • Ronnie Wirestam

    Department of Medical Radiation Physics, Lund University, Lund, Sweden

    3 shared publications
  • David Olayinka Kamson

    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    2 shared publications

Latest Publications

  • Open Access

    Dynamic glucose-enhanced MRI in brain tumors

    by Anina Seidemo, Xiang Xu, Ronnie Wirestam, Pia C. Sundgren, Peter C. M. van Zijl, Linda Knutsson

    Dynamic glucose-enhanced (DGE) MRI is an emerging imaging technique that provides information on sugar uptake with contributions from delivery (perfusion), transport (membrane permeability), and metabolism in vivo. DGE MRI contrast reflects changes in water magnetization caused by changes in sugar concentration, which can be detected through chemical exchange between water protons and sugar hydroxyl protons. Such contrast can be visualized using chemical exchange-sensitive saturation transfer (CEST), on- and off-resonance spin-lock (CESL), and $${T}_{2}$$ T 2 relaxation-based approaches. These methods enable the use of biodegradable sugars as contrast agents, which are expected to have fewer side effects than conventional gadolinium-based MRI contrast agents and are more affordable and environmentally friendly. In this review, part of the special issue “ New MR imaging techniques in Oncology, ” we provide an overview of DGE MRI and its potential applications in brain tumor imaging. We introduce the physical principles underlying the contrast mechanisms and summarize current acquisition strategies and post-processing approaches, including quantification and kinetic modeling. Technical challenges such as small signal changes, motion sensitivity, and inhomogeneities in static ( $${B}_{0}$$ B 0 ) and radiofrequency ( $${B}_{1}$$ B 1 ) magnetic fields are discussed. Special attention is given to glucose physiology and pharmacokinetics, including administration methods. Throughout, we summarize preclinical and early patient studies in brain tumors and compare DGE MRI with other functional and molecular imaging techniques using MRI and PET. Finally, we discuss future directions for clinical translation, emphasizing the need for standardized protocols and improved acquisition and post-processing strategies.

  • Open Access

    Cerebral glucose delivery, transport and metabolism: Theory and modeling using four, three and two tissue compartments

    by Anina Seidemo, Linda Knutsson, Nirbhay N Yadav, Pia C Sundgren, Ronnie Wirestam, Peter Cm van Zijl

    Flux equations describing brain D-glucose uptake are presented for up to four tissue compartments: blood, endothelial intracellular space in the blood-brain barrier (BBB), extravascular-extracellular space (EES), and intracellular space. Transport rates are described by Michaelis-Menten kinetics, including half-saturation constants ( K T ) and maximum rates for transport ( T max ) over the BBB and the cell membrane (CMB). These transport parameters and the maximum rate for hexokinase-catalyzed metabolism ( V max H K ) were determined by numerical fitting of the models to both steady-state and dynamic D-glucose uptake data in human gray matter from MRS. Two-, three-, and four-compartment results are compared, including effects of incorporating an endothelial compartment with unequal ratios ( R A / L ) of GLUT1 receptors on abluminal and luminal membranes. Four-compartment fitting with R A / L = 2.0 resulted in T max BBB = 0.804 ± 0.131 µmol/g/min, K T BBB = 6.20 ± 1.53   mM, T max CMB = 1.04 ± 0.25   µmol/g/min, K T CMB = 3.10 ± 0.70   mM and V max H K = 0.260 ± 0.039   µmol/g/min, comparing well with the simpler models. A model with at least three tissue compartments (blood, EES, cell) is essential for quantification and interpretation of dynamic glucose-enhanced (DGE) MRI data in brain tumors, where signal intensities depend on compartmental pH in addition to concentration, and where the signal contribution from the EES is dominant. It should also be relevant to PET and MR(S) studies of pathologies where the BBB is compromised.


    • 24 April 2025
    Open Access

    Dynamic glucose enhanced imaging using direct water saturation

    by Linda Knutsson, Nirbhay N. Yadav, Sajad Mohammed Ali, David Olayinka Kamson, Eleni Demetriou, Anina Seidemo, Lindsay Blair, Doris D. Lin, John Laterra, Peter C.M. van Zijl

    Dynamic glucose enhanced (DGE) MRI studies employ CEST or spin lock (CESL) to study glucose uptake. Currently, these methods are hampered by low effect size and sensitivity to motion. To overcome this, we propose to utilize exchange-based linewidth (LW) broadening of the direct water saturation (DS) curve of the water saturation spectrum (Z-spectrum) during and after glucose infusion (DS-DGE MRI). To estimate the glucose-infusion-induced LW changes (ΔLW), Bloch-McConnell simulations were performed for normoglycemia and hyperglycemia in blood, gray matter (GM), white matter (WM), CSF, and malignant tumor tissue. Whole-brain DS-DGE imaging was implemented at 3 T using dynamic Z-spectral acquisitions (1.2 s per offset frequency, 38 s per spectrum) and assessed on four brain tumor patients using infusion of 35 g of D-glucose. To assess ΔLW, a deep learning-based Lorentzian fitting approach was used on voxel-based DS spectra acquired before, during, and post-infusion. Area-under-the-curve (AUC) images, obtained from the dynamic ΔLW time curves, were compared qualitatively to perfusion-weighted imaging parametric maps. In simulations, ΔLW was 1.3%, 0.30%, 0.29/0.34%, 7.5%, and 13% in arterial blood, venous blood, GM/WM, malignant tumor tissue, and CSF, respectively. In vivo, ΔLW was approximately 1% in GM/WM, 5% to 20% for different tumor types, and 40% in CSF. The resulting DS-DGE AUC maps clearly outlined lesion areas. DS-DGE MRI is highly promising for assessing D-glucose uptake. Initial results in brain tumor patients show high-quality AUC maps of glucose-induced line broadening and DGE-based lesion enhancement similar and/or complementary to perfusion-weighted imaging.

  • Open Access

    Dynamic glucose enhanced imaging using direct water saturation

    by Linda Knutsson, Nirbhay N. Yadav, Sajad Mohammed Ali, David Olayinka Kamson, Eleni Demetriou, Anina Seidemo, Lindsay Blair, Doris D. Lin, John Laterra, Peter C. M. van Zijl

    Purpose: Dynamic glucose enhanced (DGE) MRI studies employ CEST or spin lock (CESL) to study glucose uptake. Currently, these methods are hampered by low effect size and sensitivity to motion. To overcome this, we propose to utilize exchange‐based linewidth (LW) broadening of the direct water saturation (DS) curve of the water saturation spectrum (Z‐spectrum) during and after glucose infusion (DS‐DGE MRI). Methods: To estimate the glucose‐infusion‐induced LW changes ( Δ LW) , Bloch‐McConnell simulations were performed for normoglycemia and hyperglycemia in blood, gray matter (GM), white matter (WM), CSF, and malignant tumor tissue. Whole‐brain DS‐DGE imaging was implemented at 3 T using dynamic Z‐spectral acquisitions (1.2 s per offset frequency, 38 s per spectrum) and assessed on four brain tumor patients using infusion of 35 g of D‐glucose. To assess Δ LW , a deep learning‐based Lorentzian fitting approach was used on voxel‐based DS spectra acquired before, during, and post‐infusion. Area‐under‐the‐curve (AUC) images, obtained from the dynamic Δ LW time curves, were compared qualitatively to perfusion‐weighted imaging parametric maps. Results: In simulations, Δ LW was 1.3%, 0.30%, 0.29/0.34%, 7.5%, and 13% in arterial blood, venous blood, GM/WM, malignant tumor tissue, and CSF, respectively. In vivo, Δ LW was approximately 1% in GM/WM, 5% to 20% for different tumor types, and 40% in CSF. The resulting DS‐DGE AUC maps clearly outlined lesion areas. Conclusions: DS‐DGE MRI is highly promising for assessing D‐glucose uptake. Initial results in brain tumor patients show high‐quality AUC maps of glucose‐induced line broadening and DGE‐based lesion enhancement similar and/or complementary to perfusion‐weighted imaging.


  • Open Access

    A numerical human brain phantom for dynamic glucose‐enhanced (DGE) MRI: On the influence of head motion at 3T

    by Patrick M. Lehmann, Anina Seidemo, Mads Andersen, Xiang Xu, Xu Li, Nirbhay N. Yadav, Ronnie Wirestam, Patrick Liebig, Frederik Testud, Pia Sundgren, et al.

    Purpose: Dynamic glucose‐enhanced (DGE) MRI relates to a group of exchange‐based MRI techniques where the uptake of glucose analogues is studied dynamically. However, motion artifacts can be mistaken for true DGE effects, while motion correction may alter true signal effects. The aim was to design a numerical human brain phantom to simulate a realistic DGE MRI protocol at 3T that can be used to assess the influence of head movement on the signal before and after retrospective motion correction.Methods: MPRAGE data from a tumor patient were used to simulate dynamic Z‐spectra under the influence of motion. The DGE responses for different tissue types were simulated, creating a ground truth. Rigid head movement patterns were applied as well as physiological dilatation and pulsation of the lateral ventricles and head‐motion‐induced B0‐changes in presence of first‐order shimming. The effect of retrospective motion correction was evaluated.Results: Motion artifacts similar to those previously reported for in vivo DGE data could be reproduced. Head movement of 1 mm translation and 1.5 degrees rotation led to a pseudo‐DGE effect on the order of 1% signal change. B0 effects due to head motion altered DGE changes due to a shift in the water saturation spectrum. Pseudo DGE effects were partly reduced or enhanced by rigid motion correction depending on tissue location.Conclusion: DGE MRI studies can be corrupted by motion artifacts. Designing post‐processing methods using retrospective motion correction including B0 correction will be crucial for clinical implementation. The proposed phantom should be useful for evaluation and optimization of such techniques.


  • Open Access

    Tissue response curve‐shape analysis of dynamic glucose‐enhanced and dynamic contrast‐enhanced magnetic resonance imaging in patients with brain tumor

    by Anina Seidemo, Ronnie Wirestam, Gunther Helms, Karin Markenroth Bloch, Xiang Xu, Johan Bengzon, Pia C. Sundgren, Peter C. M. van Zijl, Linda Knutsson

    Dynamic glucose‐enhanced (DGE) MRI is used to study the signal intensity time course (tissue response curve) after D‐glucose injection. D‐glucose has potential as a biodegradable alternative or complement to gadolinium‐based contrast agents, with DGE being comparable with dynamic contrast‐enhanced (DCE) MRI. However, the tissue uptake kinetics as well as the detection methods of DGE differ from DCE MRI, and it is relevant to compare these techniques in terms of spatiotemporal enhancement patterns. This study aims to develop a DGE analysis method based on tissue response curve shapes, and to investigate whether DGE MRI provides similar or complementary information to DCE MRI. Eleven patients with suspected gliomas were studied. Tissue response curves were measured for DGE and DCE MRI at 7 T and the area under the curve (AUC) was assessed. Seven types of response curve shapes were postulated and subsequently identified by deep learning to create color‐coded “curve maps” showing the spatial distribution of different curve types. DGE AUC values were significantly higher in lesions than in normal tissue (p < 0.007). Furthermore, the distribution of curve types differed between lesions and normal tissue for both DGE and DCE. The DGE and DCE response curves in a 6‐min postinjection time interval were classified as the same curve type in 20% of the lesion voxels, which increased to 29% when a 12‐min DGE time interval was considered. While both DGE and DCE tissue response curve‐shape analysis enabled differentiation of lesions from normal brain tissue in humans, their enhancements were neither temporally identical nor confined entirely to the same regions. Curve maps can provide accessible and intuitive information about the shape of DGE response curves, which is expected to be useful in the continued work towards the interpretation of DGE uptake curves in terms of D‐glucose delivery, transport, and metabolism.


  • Open Access

    Towards robust glucose chemical exchange saturation transfer imaging in humans at 3 T: Arterial input function measurements and the effects of infusion time

    by Anina Seidemo, Patrick M. Lehmann, Anna Rydhög, Ronnie Wirestam, Gunther Helms, Yi Zhang, Nirbhay N. Yadav, Pia C. Sundgren, Peter C. M. van Zijl, Linda Knutsson

    Dynamic glucose‐enhanced (DGE) magnetic resonance imaging (MRI) has shown potential for tumor imaging using D‐glucose as a biodegradable contrast agent. The DGE signal change is small at 3 T (around 1%) and accurate detection is hampered by motion. The intravenous D‐glucose injection is associated with transient side effects that can indirectly generate subject movements. In this study, the aim was to study DGE arterial input functions (AIFs) in healthy volunteers at 3 T for different scanning protocols, as a step towards making the glucose chemical exchange saturation transfer (glucoCEST) protocol more robust. Two different infusion durations (1.5 and 4.0 min) and saturation frequency offsets (1.2 and 2.0 ppm) were used. The effect of subject motion on the DGE signal was studied by using motion estimates retrieved from standard retrospective motion correction to create pseudo‐DGE maps, where the apparent DGE signal changes were entirely caused by motion. Furthermore, the DGE AIFs were compared with venous blood glucose levels. A significant difference (p = 0.03) between arterial baseline and postinfusion DGE signal was found after D‐glucose infusion. The results indicate that the measured DGE AIF signal change depends on both motion and blood glucose concentration change, emphasizing the need for sufficient motion correction in glucoCEST imaging. Finally, we conclude that a longer infusion duration (e.g. 3–4 min) should preferably be used in glucoCEST experiments, because it can minimize the glucose infusion side effects without negatively affecting the DGE signal change.